A controlled trial of plasma lipid reduction in peripheral atherosclerosis--an interim report.
D000328:Adult; D001161:Arteriosclerosis / Q000097:blood* / Q000150:complications; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D007383:Intermittent Claudication / Q000097:blood* / Q000000981:diagnostic imaging / Q000628:therapy; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011859:Radiography; D011897:Random Allocation; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate